Anti-Inflammatory potential of newly synthesized 4-[(Butylsulfinyl)methyl]-1,2-benzenediol in lipopolysaccharide-stimulated BV2 Microglia

Molecules

Volumn 19, Issue 10, 2014, Pages 16609-16623

  Jo, Guk Heui ^a   Choi, Il Whan ^b   Jeong, Jin Woo ^c   Kim, Gi Young ^d   Kim, Jinwoo ^e   Suh, Hongsuk ^e   Ryu, Chung Ho ^c   Kim, Wun Jae ^f   Choi, Yung Hyun ^a  

^a Dong Eui University   (South Korea)

^b Inje University   (South Korea)

^c Gyeongsang National University   (South Korea)

^d Jeju National University   (South Korea)

^e Pusan National University   (South Korea)

^f Chungbuk National University College of Medicine   (South Korea)

Author keywords

2 benzenediol; 4 (butylsulfinyl)methyl 1; Anti inflammation; BV2 microglia; MAPKs; NF B; PI3K Akt

Indexed keywords

4-((BUTYLSULFINYL)METHYL)-1,2-BENZENEDIOL; ANTIINFLAMMATORY AGENT; CATECHOL; CATECHOL DERIVATIVE; CYCLOOXYGENASE 2; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC-OXIDE REDUCTASE; NOS2 PROTEIN, MOUSE; OXIDOREDUCTASE; PROSTAGLANDIN E2; PTGS2 PROTEIN, MOUSE; SULFOXIDE;

ANIMAL; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROGLIA; MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CATECHOLS; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; OXIDOREDUCTASES; SIGNAL TRANSDUCTION; SULFOXIDES;

EID: 84911930236     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules191016609     Document Type: Article

References (34)

1. Lind, L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003, 169, 203-214.
2. Bertolini, A.; Ottani, A.; Sandrini, M. Dual acting anti-inflammatory drugs: A reappraisal. Pharmacol. Res. 2001, 44, 437-450.
3. Napoli, I.; Neumann, H. Microglial clearance function in health and disease. Neuroscience 2009, 158, 1030-1038.
4. Loane, D.J.; Byrnes, K.R. Role of microglia in neurotrauma. Neurotherapeutics 2010, 7, 366-377.
5. Vane, J.R.; Mitchell, J.A.; Appleton, I.; Tomlinson, A.; Bishop-Bailey, D.; Croxtall, J.; Willoughby, D.A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 1994, 91, 2046-2050.
6. Dandona, P.; Chaudhuri, A.; Dhindsa, S. Proinflammatory and prothrombotic effects of hypoglycemia. Diabetes Care 2010, 33, 1686-1687.
7. Salvemini, D.; Marino, M.H. Inducible nitric oxide synthase and inflammation. Expert. Opin. Investig. Drugs 1998, 7, 65-75.
8. Harris, R.E.; Beebe-Donk, J.; Schuller, H.M. Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. Oncol. Rep. 2002, 9, 693-695.
9. Block, M.L.; Zecca, L.; Hong, J.S. Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8, 57-69.
10. Morris, P.E.; Olmstead, L.E.; Howard-Carroll, A.E.; Dickens, G.R.; Goltz, M.L.; Courtney-Shapiro, C.; Fanti, P. In vitro and in vivo effects of HS-1605 on murine alveolar macrophage TNF alpha production. Inflammation 1999, 23, 231-239.
11. Aggarwal, B.B.; Natarajan, K. Tumor necrosis factors: Developments during the last decade. Eur. Cytokine Netw. 1996, 7, 93-124.
12. Medzhitov, R.; Preston-Hurlburt, P.; Janeway, C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388, 394-397.
13. Pasare, C.; Medzhitov, R. Toll-like receptors: Linking innate and adaptive immunity. Microbes Infect.2004, 6, 1382-1387.
14. Guha, M.; Mackman, N. LPS induction of gene expression in human monocytes. Cell. Signal.2001, 13, 85-94.
15. Li, Q.; Verma, I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2002, 2, 725-734.
16. Anwar, M.A.; Basith, S.; Choi, S. Negative regulatory approaches to the attenuation of Toll-like receptor signaling. Exp. Mol. Med. 2013, 45, doi:10.1038/emm.2013.28.
17. Lehnardt, S.; Lachance, C.; Patrizi, S.; Lefebvre, S.; Follett, P.L.; Jensen, F.E.; Rosenberg, P.A.; Volpe, J.J.; Vartanian, T. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 2002, 22, 2478-2486.
18. Moreillon, P.; Majcherczyk, P.A. Proinflammatory activity of cell-wall constituents from gram-positive bacteria. Scand. J. Infect. Dis. 2003, 35, 632-641.
19. Marshall, J.C. Lipopolysaccharide: An endotoxin or an exogenous hormone? Clin. Infect. Dis.2005, 41, S470-S480.
20. Ishii, Y.; Okamura, T.; Inoue, T.; Tasaki, M.; Umemura, T.; Nishikawa, A. Dietary catechol causes increased oxidative DNA damage in the livers of mice treated with acetaminophen. Toxicology 2009, 263, 93-99.
21. Sarkar, D.; Saha, P.; Gamre, S.; Bhattacharjee, S.; Hariharan, C.; Ganguly, S.; Sen, R.; Mandal, G.; Chattopadhyay, S.; Majumdar, S.; et al. Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-kappaB pathway. Int. Immunopharmacol. 2008, 8, 1264-1271.
22. Majtan, J.; Majtan, V. Dimethyl sulfoxide attenuates TNF-α-induced production of MMP-9 in human keratinocytes. J. Toxicol. Environ. Health A 2011, 74, 1319-1322.
23. Xing, L.; Remick, D.G. Mechanisms of dimethyl sulfoxide augmentation of IL-1 beta production. J. Immunol. 2005, 174, 6195-6202.
24. Ramoutar, R.R.; Brumaghim, J.L. Antioxidant and anticancer properties and mechanisms of inorganic selenium, oxo-sulfur, and oxo-selenium compounds. Cell Biochem. Biophys. 2010, 58, 1-23.
25. Kim, H.J.; Noh, J.S.; Kwon, M.J.; Kwon, M.J.; Song, S.; Suh, H.; Kim, M.J.; Song, Y.O. Lipid lowering and antioxidant effects of newly synthesized 4-[(Butylsulfinyl)methyl]-1,2-benzenediol (SMBD) in diet-induced hypercholesterolemic rabbits. Bull. Korean Chem. Soc. 2010, 31, 3327-333.
26. Uto, T.; Fujii, M.; Hou, D.X. 6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide-Activated murine macrophages. Biochem. Pharmacol. 2005, 70, 1211-1221.
27. Dan, H.C.; Cooper, M.J.; Cogswell, P.C.; Duncan, J.A.; Ting, J.P.; Baldwin, A.S. Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK. Genes Dev.2008, 22, 1490-1500.
28. Kanno, S.; Shouji, A.; Tomizawa, A.; Hiura, T.; Osanai, Y.; Ujibe, M.; Obara, Y.; Nakahata, N.; Ishikawa, M. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages. Life Sci. 2006, 78, 673-681.
29. Lin, W.J.; Yeh, W.C. Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock. Shock 2005, 24, 206-209.
30. Blatteis, C.M.; Li, S.; Li, Z.; Perlik, V.; Feleder, C. Signaling the brain in systemic inflammation: The role of complement. Front. Biosci. 2004, 9, 915-931.
31. Dinarello, C.A. Proinflammatory cytokines. Chest 2000, 118, 503-508.
32. Cunningham, C. Microglia and neurodegeneration: The role of systemic inflammation. Glia 2013, 61, 71-90.
33. Akira, S.; Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4, 499-511.
34. Park, C.M.; Song, Y.S. Luteolin and luteolin-7-O-glucoside inhibit lipopolysaccharide-induced inflammatory responses through modulation of NF-κB/AP-1/PI3K-Akt signaling cascades in RAW 264.7 cells. Nutr. Res. Pract. 2013, 7, 423-429.